click below
click below
Normal Size Small Size show me how
CNS 2-3
BDK
| Pharmacologic Category | Generic Name | Brand Name | Common Indications | Essential Knowledge |
|---|---|---|---|---|
| Second- generation antipsychotic | risperidone (PO, IM) | PO: Risperdal IM: Risperdal Consta | Schizophrenia | Key Side Effects: sedation, EPS, xerostomia, constipation, orthostatic hypotension, weight gain, hyperglycemia, US Boxed Warnings: elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death |
| Second- generation antipsychotic | olanzapine (PO, IM) | Zyprexa | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants | Key Side Effects: sedation, EPS, xerostomia, constipation, orthostatic hypotension, weight gain, hyperglycemia, US Boxed Warnings: elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death |
| Second- generation antipsychotic | lurasidone (PO) | Latuda | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants | sedation, EPS, constipation, orthostatic hypotension, weight gain BW: antidepressants increase the risk of suicidal thinking, elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death CI with strong 3A4 |
| Second- generation antipsychotic | quetiapine (PO) | Seroquel, Seroquel XR | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants | sedation, EPS, constipation, orthostatic hypotension, weight gain, BW: antidepressants increase the risk of suicidal thinking in the youth; elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death |
| Second- generation antipsychotic | aripiprazole (PO, IM) | PO/IM: Abilify; IM: Aristada | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants | akathisia, restlessness, sedation, EPS, constipation, orthostatic hypotension, weight gain BW: increase the risk of suicidal thinking and behavior in youth; elderly patients with dementia-related psycho treated with antipsychotic drugs at increased risk |
| Second- generation antipsychotic | clozapine (PO) | Clozaril | Treatment- resistant schizophrenia | sedation, constipation, orthostatic hypotension, sialorrhea, hyperglycemia, weight gain BW: may cause severe neutropenia; may cause orthostatic hypotension, bradycardia, and syncope; seizures; fatal myocarditis and cardiomyopathy; elderly patients |
| First-generation antipsychotic | haloperidol (PO, IV, IM) | Haldol | Schizophrenia | Key Side Effects: sedation, EPS, parkinsonism, xerostomia, orthostatic hypotension, weight gain, QTc prolongation, US Boxed Warnings: elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death |
| Antimigraine | rizatriptan (PO) | Maxalt | Migraine | Key Side Effects: fatigue, somnolence, dizziness, chest tightness, paresthesias Other Notes: CI in ischemic heart disease, history of stroke or TIA, peripheral vascular disease, and uncontrolled hypertension |
| Antimigraine | sumatriptan (PO, intranasal, SQ) | Imitrex | Migraine | Key Side Effects: fatigue, somnolence, dizziness, chest tightness, paresthesias Other Notes: CI in ischemic heart disease, history of stroke or TIA, peripheral vascular disease, and uncontrolled hypertension |
| Antimanic agent | lithium (PO) | Lithobid | Bipolar disorder | tremor, acne, hypothyroidism, weight gain, polyuria, polydipsia, GI upset BW: ability to promptly monitor levels is necessary Other Notes: narrow therapeutic index drug; avoid in pregnancy |
| Cholinesterase inhibitor | donepezil (PO, transdermal) | PO: Aricept, Transdermal: Adlarity | Dementia | Key Side Effects:L nausea, vomiting, diarrhea |
| N-methyl D- aspartate (NMDA) antagonist | memantine (PO) | Namenda | Dementia | Key Side Effects: constipation, confusion, dizziness, headache |
| Decarboxylase inhibitor (carbidopa), dopamine precursor (levodopa) | carbidopa and levodopa (PO) | Sinemet, Sinemet CR | Parkinson's disease | Key Side Effects: nausea, orthostatic hypotension, dyskinesias Other Notes: CI within 14 days of MAOI, CI in narrow-angle glaucoma; do not abruptly discontinue |
| Dopamine agonist | ropinirole (PO) | Requip | Parkinson's disease, RLS | Key Side Effects: nausea, hallucinations, dizziness, drowsiness, compulsive behaviors, orthostasis |
| Dopamine agonist | pramipexole (PO) | Mirapex | Parkinson's disease, RLS | Key Side Effects: nausea, hallucinations, dizziness, drowsiness, compulsive behaviors, orthostasis |
| Selective alpha2a agonis | guanfacine (PO) | Intuniv | ADHD, HTN | Key Side Effects: bradycardia, hypotension, sedation, skin rash, xerostomia, constipation Other Notes: do not abruptly discontinue |
| CNS stimulant (C-II) | methylphenidate (PO, transdermal) | PO: Concerta, Ritalin Patch: Daytrana | ADHD, narcolepsy | Key Side Effects: insomnia, headache, anxiety, weight loss, decreased appetite, hypertension US Boxed Warnings: high potential for abuse, Other Notes: CI within 14 days of MAOI |
| CNS stimulant (C-II) | lisdexamfetamine (PO | Vyvanse | ADHD | Key Side Effects: insomnia, headache, anxiety, weight loss, decreased appetite, hypertension US Boxed Warnings: high potential for abuse, Other Notes: CI within 14 days of MAOI |
| CNS stimulant (C-II) | dextroamphetamine and amphetamine (PO) | Adderall, Adderall XR | ADHD, narcolepsy | Key Side Effects: insomnia, headache, anxiety, weight loss, decreased appetite, hypertension US Boxed Warnings: high potential for abuse, Other Notes: CI within 14 days of MAOI |
| CNS stimulant (C-II) | dexmethylphenidate (PO | Focalin, Focalin XR | ADHA | Key Side Effects: insomnia, headache, anxiety, weight loss, decreased appetite, hypertension US Boxed Warnings: high potential for abuse, Other Notes: CI within 14 days of MAOI |